About the Company
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BMY News
Is Bristol Myers Squibb Stock a Buy?
That's the case with biotech giant Bristol Myers Squibb (NYSE: BMY). The drugmaker has seen its shares drop by 22% over the ...
Bristol-Myers Squibb Company (BMY) Impacted by Delay in New Product Launches
Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2023 investor letter. A ...
Bristol Myers Squibb cuts hundreds of Mirati staffers months after closing $5.8B buyout
Two months after closing its multibillion-dollar acquisition of Mirati Therapeutics, Bristol Myers Squibb is bidding adieu to ...
Bristol-Myers Squibb Co
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bristol-Myers Squibb Earnings: BMY Stock Bounces on Strong Q2, Guidance
Bristol-Myers Squibb (NYSE:BMY) reported earnings per share of $1.18 for the second quarter of 2019. This is better than the ...
Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes
Company Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United Kingdom ...
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics
Bristol Myers Squibb (BMS) has successfully completed its acquisition of Karuna Therapeutics, Inc. Through this transaction, ...
Bristol Myers' Opdivo-Yervoy combo meets main goal in liver cancer trial
Bristol Myers Squibb said on Wednesday a combination of Opdivo and Yervoy met the main goal of a late-stage study evaluating ...
Bristol-Myers Squibb Co BMY
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bristol Myers Squibb Completes Acquisition Of Karuna Therapeutics - Quick Facts
Bristol Myers Squibb (BMY) has successfully completed its acquisition of Karuna Therapeutics, Inc. Karuna shares have ceased trading ...
Bristol-Myers Squibb Co.
Analysts say these cheap stocks have plenty of upside.
Loading the latest forecasts...